Generate a tailored SOP for Dr. Martin Sauvageau. Improve your application with a focused, well-structured draft.
Martin Sauvageau obtained his BSc in Microbiology and Immunology from Université de Montréal and later earned his PhD from McGill University, focusing on the epigenetic regulation of leukemic stem cells. He completed his postdoctoral fellowship at Harvard University’s Broad Institute and subsequently served as a senior research associate at Beth Israel Deaconess Medical Center affiliated with Harvard Medical School. In October 2017, he became an Assistant Professor and the Director of the RNA Noncoding Disease Mechanisms Laboratory at the Montreal Clinical Research Institute (IRCM). Dr. Sauvageau's research, funded by numerous agencies such as the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC), investigates the functional characterization and mechanisms of long noncoding RNAs (lncRNAs) in relation to disease. His lab combines functional genomics and proteomics with CRISPR-based techniques to elucidate how lncRNAs influence cellular functions and contribute to disease. Additionally, he has been involved in various research projects focusing on lncRNA regulation and their implications in cancer and other diseases.
Montreal Clinical Research Institute (IRCM) • Montréal
Leading the RNA Noncoding Disease Mechanisms Laboratory.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.